ID   LaNCE hiPSC-42
AC   CVCL_WR92
SY   hiPSC-42; iPS-42-MCA; iPS-42; iPS-CT2; LANCEi018-A
DR   hPSCreg; LANCEi018-A
DR   Wikidata; Q95981253
RX   PubMed=29433076;
RX   PubMed=31710912;
CC   From: National Laboratory of Embryonic Stem Cell (LaNCE), University of Sao Paulo; Sao Paulo; Brazil.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=29433076
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 9
ST   D16S539: 11,13
ST   D18S51: 14
ST   D19S433: 11,13
ST   D21S11: 30,32.2
ST   D2S1338: 19,20
ST   D3S1358: 14,17
ST   D5S818: 10,13
ST   D7S820: 8,9
ST   D8S1179: 14
ST   FGA: 23,26
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 14,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 5
//
RX   PubMed=29433076; DOI=10.1016/j.scr.2018.01.030;
RA   Sarafian R.D., Morato-Marques M., Borsoi J., Pereira L.V.;
RT   "Monitoring cell line identity in collections of human induced
RT   pluripotent stem cells.";
RL   Stem Cell Res. 28:66-70(2018).
//
RX   PubMed=31710912; DOI=10.1016/j.scr.2019.101640;
RA   Tofoli de Araujo F., Chien H.-F., Barbosa E.R., Pereira L.V.;
RT   "Generation of 5 hiPSC lines derived from three unrelated idiopathic
RT   Parkinson disease patients and two unrelated healthy control
RT   individuals.";
RL   Stem Cell Res. 41:101640-101640(2019).
//